NEWSLETTER APRIL 2020
IDDI and COVID-19 – A Message from Damien Tremolet, IDDI CEO
As a result of the outbreak of COVID-19, IDDI has implemented strict measures to preserve the health and safety of our employees and their families.
PRESENTATION: Integration of biomarker validation in clinical development a statistical perspective
As statistical experts in validating IVDs based on single biomarkers and biomarkers panels, IDDI has presented on Biomarker validation at 5th Annual Biomarker and Companion Diagnostics Conference in San Diego.
FDA and EMA Release Guidance on Conduct of Clinical Trials during Covid-19 Pandemic
On March 27th 2020, the FDA issued an updated ‘Guidance for Industry, Investigators, and Institutional Review Boards’ on ‘Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic’
Similarly the EMA issues a Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic
Please CLICK HERE if you want to discuss with IDDI experts whether these measures impact your trial and how to put in place a mitigation plan.
WE KEEP ON HIRING!
Tremendous opportunities in Belgium and in the US. Apply today!
BUSINESS CONTINUES – Just tons more TCs than ever before!
Working great with our colleagues (consultants & Bus Ops) to deliver for our clients in these challenging times!
– Erik Falvey, Senior Director, Business Development Europe, firstname.lastname@example.org
– Vicky Martin, Senior Director, US Business Development, email@example.com
– Robert Whitaker, Director, Business Development, West Coast USA, firstname.lastname@example.org
WEBINARS & PRESENTATIONS
In this disruptive time, stay safe and take the opportunity to discover our complimentary expert webinars.
COMBINING PASSION, SCIENCE AND EXPERIENCE
TO ENSURE YOUR CLINICAL DATA IS READY FOR SUBMISSION